Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cosmetics Related	5.16M	3.85M	4.02M	13.35M	14.15M
Cosmetics Related Growth	33.99%	-4.23%	-69.88%	-5.61%	9.89%
Antibody Related Business	964.37M	812.85M	790.60M	637.47M	494.10M
Antibody Related Business Growth	18.64%	2.81%	24.02%	29.02%	4.86%
Genetically Modified Silkworm Development Project	-	-	-	-	29.80M
Genetically Modified Silkworm Development Project Growth	-	-	-	-	18.03%
Unallocated Adjustment	-	-	-	-3.24M	-16.76M
Inspection Business	-	-	-	-	81.46M
Inspection Business Growth	-	-	-	-	13.72%
Total	969.53M	816.70M	794.62M	647.58M	602.75M
Total Growth	18.71%	2.78%	22.71%	7.44%	4.52%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Japan	589.36M	549.71M	537.89M	490.31M	489.84M
Japan Growth	7.21%	2.20%	9.70%	0.10%	13.85%
United States	196.74M	122.92M	131.49M	74.40M	49.52M
United States Growth	60.05%	-6.51%	76.74%	50.24%	-39.20%
China	68.46M	59.41M	-	-	-
China Growth	15.24%	-	-	-	-
Others	114.98M	84.66M	63.81M	33.12M	27.66M
Others Growth	35.81%	32.68%	92.65%	19.73%	7.18%
Germany	-	-	61.44M	49.75M	35.73M
Germany Growth	-	-	23.50%	39.22%	-8.86%
Total	969.53M	816.70M	794.62M	647.57M	602.75M
Total Growth	18.71%	2.78%	22.71%	7.44%	4.52%

Source: S&P Global Market Intelligence.